Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases
- PMID: 33132902
- PMCID: PMC7572858
- DOI: 10.3389/fnagi.2020.581374
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases
Abstract
Aberrant accumulation of misfolded proteins into amyloid deposits is a hallmark in many age-related neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). Pathological inclusions and the associated toxicity appear to spread through the nervous system in a characteristic pattern during the disease. This has been attributed to a prion-like behavior of amyloid-type aggregates, which involves self-replication of the pathological conformation, intercellular transfer, and the subsequent seeding of native forms of the same protein in the neighboring cell. Molecular chaperones play a major role in maintaining cellular proteostasis by assisting the (re)-folding of cellular proteins to ensure their function or by promoting the degradation of terminally misfolded proteins to prevent damage. With increasing age, however, the capacity of this proteostasis network tends to decrease, which enables the manifestation of neurodegenerative diseases. Recently, there has been a plethora of studies investigating how and when chaperones interact with disease-related proteins, which have advanced our understanding of the role of chaperones in protein misfolding diseases. This review article focuses on the steps of prion-like propagation from initial misfolding and self-templated replication to intercellular spreading and discusses the influence that chaperones have on these various steps, highlighting both the positive and adverse consequences chaperone action can have. Understanding how chaperones alleviate and aggravate disease progression is vital for the development of therapeutic strategies to combat these debilitating diseases.
Keywords: disaggregation; molecular chaperones and Hsps; neurodegenarative diseases; prion-like spreading; proteostasis.
Copyright © 2020 Tittelmeier, Nachman and Nussbaum-Krammer.
Figures




Similar articles
-
Protein Quality Control by Molecular Chaperones in Neurodegeneration.Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017. Front Neurosci. 2017. PMID: 28428740 Free PMC article. Review.
-
Walking the tightrope: proteostasis and neurodegenerative disease.J Neurochem. 2016 May;137(4):489-505. doi: 10.1111/jnc.13575. Epub 2016 Mar 8. J Neurochem. 2016. PMID: 26872075 Review.
-
Engineering enhanced protein disaggregases for neurodegenerative disease.Prion. 2015;9(2):90-109. doi: 10.1080/19336896.2015.1020277. Prion. 2015. PMID: 25738979 Free PMC article. Review.
-
[Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].Brain Nerve. 2012 Jun;64(6):665-74. Brain Nerve. 2012. PMID: 22647474 Review. Japanese.
-
Involvement of molecular chaperone in protein-misfolding brain diseases.Biomed Pharmacother. 2022 Mar;147:112647. doi: 10.1016/j.biopha.2022.112647. Epub 2022 Feb 8. Biomed Pharmacother. 2022. PMID: 35149361 Review.
Cited by
-
Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field.Cells. 2022 Jun 4;11(11):1838. doi: 10.3390/cells11111838. Cells. 2022. PMID: 35681533 Free PMC article. Review.
-
14-3-3τ as a Modulator of Early α-Synuclein Multimerization and Amyloid Formation.ACS Chem Neurosci. 2024 May 1;15(9):1926-1936. doi: 10.1021/acschemneuro.4c00100. Epub 2024 Apr 18. ACS Chem Neurosci. 2024. PMID: 38635928 Free PMC article.
-
Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration.ACS Chem Neurosci. 2024 Aug 7;15(15):2665-2694. doi: 10.1021/acschemneuro.4c00184. Epub 2024 Jul 12. ACS Chem Neurosci. 2024. PMID: 38996083 Free PMC article. Review.
-
Proteomic Markers in the Muscles and Brain of Pigs Recovered from Hemorrhagic Stroke.Genes (Basel). 2022 Nov 24;13(12):2204. doi: 10.3390/genes13122204. Genes (Basel). 2022. PMID: 36553471 Free PMC article.
-
Amyloidosis: What does pathology offer? The evolving field of tissue biopsy.Front Cardiovasc Med. 2022 Dec 5;9:1081098. doi: 10.3389/fcvm.2022.1081098. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36545023 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous